Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Masafumi Ikeda
O-021: Ramucirumab in Advanced Hepatocellular Carcinoma and Elevated Alpha-fetoprotein Following Sorafenib: Outcomes by Prior Transarterial Chemoembolisation From Two Randomised, Double-blind, Placebo-controlled Phase 3 Studies (REACH-2 and REACH)
Access the abstract
Yoon-Koo Kang , MD, PhD;
Chia-Jui Yen ;
Peter R. Galle , MD, PhD;
Josep Llovet ;
Eric Assenat ;
Giovanni Brandi ;
Kenta Motomura ;
Takuji Okusaka ;
Mark Karwal ;
Ari Baron ;
Masafumi Ikeda ;
Kun Liang ;
Richard A. Hubner ;
Chunxiao Wang ;
Masatoshi Kudo , MD, PhD;
Ryan Widau ;
Tim Meyer ;
William Schelman ;
Richard S. Finn ;
Andrew Zhu ;
07/31/2019
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Upcoming Events
February 2 – February 5
February 27 – March 1
March 17 – March 19
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 5
April 30 – May 4
May 1 – May 3
May 19 – May 21
See Full Calendar